Swedencare (SECARE) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Apr, 2026Executive summary
Q4 2025 delivered 11% organic growth, with double-digit gains in key brands like NaturVet (33%) and ProDen PlaqueOff (17%), but profitability declined due to one-off costs, higher marketing spend, and inventory write-offs.
Organizational improvements and enhanced cost controls have been implemented to address Q4 issues and improve profitability in 2026.
Online, pet retail, and branded vet sales grew strongly, while contract manufacturing, especially in liquid dermatology, was soft.
Major product launches and marketing campaigns, particularly for NaturVet and Walmart, drove sales but also increased costs.
The board proposed a dividend increase to 0.28 SEK per share.
Financial highlights
Q4 2025 revenue reached SEK 682.3 million, up 3% (11% organic), with a negative 12% currency impact and 4% acquired growth.
Full-year 2025 net revenue was SEK 2.7 billion, up from SEK 2.5 billion, with 9% organic growth.
Operational gross margin for Q4 was 56.8%, impacted by inventory write-offs and low-margin display campaigns.
Operational EBITDA for Q4 was SEK 108.6 million (15.9% margin), down 25% year-over-year; full-year EBITDA was SEK 511 million (19% margin).
Net debt to EBITDA rose to 2.9 at year-end, impacted by acquisitions and lower EBITDA.
Cash conversion was 41% for the quarter, with significant tax payments affecting operating cash flow.
Outlook and guidance
Expectation of improved profitability and gross margins in 2026 as one-off costs subside and cost controls take effect.
New financial targets: annual double-digit organic growth, operational EBITDA margin above 26% midterm, and net debt/EBITDA below 2.0 long-term.
Marketing spend will align more closely with sales growth, avoiding mismatches seen in Q4.
Pharma segment and online sales, especially on Amazon, are expected to be key growth and margin drivers.
Continued investments in manufacturing and expansion into Big Box retail and online channels are expected to drive future growth.
Latest events from Swedencare
- Improved margins and strong sales drive a positive outlook as operational challenges ease.SECARE
Pre-close call20 Mar 2026 - Q2 revenue up 10% with margin gains, strong European growth, and strategic acquisitions.SECARE
Q2 20243 Feb 2026 - Q3 saw 9% organic growth, higher margins, and strong European and dental segment gains.SECARE
Q3 202419 Jan 2026 - Q3 2025 saw record growth, robust margins, and new targets for global expansion and profitability.SECARE
SEB Nordic Seminar presentation16 Jan 2026 - Q1 2025 delivered 7% revenue growth, strong cash flow, and key acquisitions for future expansion.SECARE
Q1 202523 Dec 2025 - Record sales and margins in 2024, with Europe and dental segments leading growth; NaturVet set for 2025 rebound.SECARE
Q4 202417 Dec 2025 - Record Q3 revenue and profitability, led by strong organic growth and U.S. retail expansion.SECARE
Q3 202514 Dec 2025 - Q2 2025 saw 3% sales growth and margin pressure, with double-digit growth expected in H2.SECARE
Q2 202516 Nov 2025